Kristie L. Kahl

In this episode of the “CURE Talks Cancer” podcast, we spoke with Mark Hoffman, a patient with chronic lymphocytic leukemia, about his diagnosis and treatment journey.

In this episode of the “CURE Talks Cancer” podcast, Dr. Dan Pollyea discusses the basics of AML, as well as treatment options currently available for patients.

The Food and Drug Administration approved the supplemental new drug application for Iclusig (ponatinib) to treat patients with chronic-phase chronic myeloid leukemia (CML) with resistance or intolerance to at least two prior kinase inhibitors.

In this episode of the “CURE Talks Cancer” podcast, we spoke with Dr. Asher Chanan-Khan about current standards of care for Waldenstrom macroglobulinemia, as well as a clinical trial looking at a novel therapy.

Prior to receiving behavioral interventions, more than half of participating young survivors of breast cancer were considered clinically depressed. That number dropped to 30% after participants received mindfulness meditation and survivorship education classes.

Younger age, breast cancer diagnosis, Medicaid insurance and treatment type were associated with an increased risk for women becoming new chronic users of opioids or sedatives/hypnotics following mastectomy with reconstructive surgery.

In this episode of the “CURE Talks Cancer” podcast, we spoke with Dr. Ezra Cohen and two patients with advanced cutaneous squamous cell carcinoma about the disease, its treatments and their recommendations for others.

CURE® spoke with Dr. David Cooke, on behalf of the American Lung Association, on addressing racial disparities in lung cancer screening and care.

On behalf of the National Pancreas Foundation, Dr. Diane Simeone offers insight into early detection options for those at increased risk of pancreatic cancer, including surveillance and screening.

Treatment with a novel immuno-oncology therapy demonstrated a manageable safety profile with preliminary efficacy in patients with metastatic castration-resistant prostate cancer.

In this episode of the “CURE Talks Cancer” podcast, we spoke with television journalist Katie Couric and Susan G. Komen CEO Paula Schneider about their experiences with cancer, and the advice they offered their pre-cancer selves.

In this episode of the “CURE Talks Cancer” podcast, we looked back on CURE’s Lung Cancer Heroes event and recognized each winner that helps bring together the lung cancer community to raise awareness.

Organized as a virtual event, the DONNA Foundation’s 2021 National Marathon to Finish Breast Cancer will allow participants to run in their neighborhoods — or on their treadmills.

How does a metastatic cancer diagnosis affect families, especially children? CURE® spoke with Kate Watson, a patient ambassador for METAvivor, about the tricky balance of protecting and empowering kids.

After granting accelerated approval in 2018, the Food and Drug Administration approved Venclexta in combination with Vidaza, Dacogen or low dose cytarabine in newly diagnosed patients with AML.